This trial is terminated!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Breast Cancer
and you are
between 18 and 120
years old
-
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

RATIONALE: Studying samples of blood from patients with breast cancer in the laboratory may help doctors identify and learn more about biomarkers related to tamoxifen resistance. PURPOSE: This laboratory study is looking at tamoxifen resistance in women with stage I, stage II, stage IIIA, or stage IIIB breast cancer.

Provided treatments

  • Drug: tamoxifen citrate
  • Genetic: gene expression analysis
  • Genetic: protein expression analysis
  • Other: immunoenzyme technique
  • Other: laboratory biomarker analysis
Tris trial is registered with FDA with number: NCT00899197. The sponsor of the trial is Wake Forest University Health Sciences and it is looking for 2 volunteers for the current phase.
Official trial title:
Tamoxifen Resistance in Breast Cancer